{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:10:54Z","timestamp":1780384254831,"version":"3.54.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.transci.2021.103173","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T11:17:13Z","timestamp":1624015033000},"page":"103173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Overlap Stevens Johnson Syndrome\/Toxic Epidermal Necrolysis developed due to the use of toxic-dose vinblastine in case of Langerhans Cell Histiocytosis(Letterer-Siwe)"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2586-5954","authenticated-orcid":false,"given":"Oktay","family":"Perk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9458-2803","authenticated-orcid":false,"given":"Tan\u0131l","family":"Kendirli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Din\u00e7aslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Azapa\u011fas\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5565-6061","authenticated-orcid":false,"given":"Gokcen","family":"Meral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Jun. (6)","key":"10.1016\/j.transci.2021.103173_bib0005","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1111\/1523-1747.ep12388434","article-title":"The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification","volume":"102","author":"Roujeau","year":"1994","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.transci.2021.103173_bib0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/archderm.1995.01690170041005","article-title":"Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes","volume":"131","author":"Assier","year":"1995","journal-title":"Arch Dermatol"},{"issue":"Jan. (1)","key":"10.1016\/j.transci.2021.103173_bib0015","first-page":"89","article-title":"Fatality involving vinblastine overdose as a result of a complex medical error","volume":"59","author":"K\u0142ys","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"issue":"Oct. (5)","key":"10.1016\/j.transci.2021.103173_bib0020","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/vde.12142","article-title":"Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: a comparative review","volume":"25","author":"Yager","year":"2014","journal-title":"Vet Dermatol"},{"issue":"Apr.\u2013Jun. (2)","key":"10.1016\/j.transci.2021.103173_bib0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3109\/08880019109033444","article-title":"Overdose of vinblastine in a child with Langerhans\u2019 cell histiocytosis: toxicity and salvage therapy","volume":"8","author":"Conter","year":"1991","journal-title":"Pediatr Hematol Oncol J"},{"issue":"Sep. (3)","key":"10.1016\/j.transci.2021.103173_bib0030","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/pbc.20284","article-title":"A case of vinblastine overdose managed with plasma exchange","volume":"45","author":"Spiller","year":"2005","journal-title":"Pediatr Blood Cancer"},{"issue":"Nov. (10)","key":"10.1016\/j.transci.2021.103173_bib0035","first-page":"1134","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone secondary to vinblastine overdose","volume":"117","author":"Winter","year":"1977","journal-title":"Can Med Assoc J"},{"issue":"Jul. (8812)","key":"10.1016\/j.transci.2021.103173_bib0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0140-6736(92)93272-O","article-title":"Favourable outcome after plasmapheresis for vincristine overdose","volume":"340","author":"Pierga","year":"1992","journal-title":"Lancet"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221001397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221001397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:52:21Z","timestamp":1761468741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050221001397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1473050221001397"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2021.103173","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overlap Stevens Johnson Syndrome\/Toxic Epidermal Necrolysis developed due to the use of toxic-dose vinblastine in case of Langerhans Cell Histiocytosis(Letterer-Siwe)","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2021.103173","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103173"}}